featured
Quality-of-Life Outcomes Associated With Dupilumab for the Treatment of Atopic Dermatitis in Young Children
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: results from a placebo-controlled, phase 3 study
J Am Acad Dermatol 2024 Sep 28;[EPub Ahead of Print], AS Paller, JI Silverberg, EL Simpson, MJ Cork, PD Arkwright, Z Chen, A Bansal, R Prescilla, Z Wang, AR MarcoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.